Table 5
Expression of β1-integrin according to the clinicopathologic findings
Variable | Expression | Density of band |
|
|
+ | – | P-value | Mean±SD | P-value |
Sex | | | 0.485 | | 0.667 |
Male (16) | 14 | 2 | | 0.25±0.12 | |
Female (14) | 14 | 0 | | 0.31±0.22 | |
Age (yr) | | | 0.724 | | 0.498 |
<60 (16) | 15 | 1 | | 0.27±0.20 | |
≥60 (14) | 13 | 1 | | 0.29±0.15 | |
Tumor location | | | 0.724 | | 0.11 |
Colon (16) | 15 | 1 | | 0.35±0.21 | |
Rectum (14) | 13 | 1 | | 0.20±0.08 | |
Stage | | | 0.033 | | 0.21 |
I (7) | 5 | 2 | | 0.25±0.18 | |
II (12) | 12 | 0 | | 0.27±0.14 | |
III (11) | 11 | 0 | | 0.31±0.22 | |
Node metastasis | | | 0.352 | | 0.735 |
Absent (19) | 17 | 2 | | 0.27±0.15 | |
Present (11) | 11 | 0 | | 0.31±0.21 | |
Vascular invasion | | | 0.69 | | 0.627 |
Absent (25) | 23 | 2 | | 0.30±0.19 | |
Present (5) | 5 | 0 | | 0.21±0.06 | |
Lymphatic invasion | | | 0.483 | | 0.982 |
Absent (21) | 19 | 2 | | 0.29±0.19 | |
Present (9) | 9 | 0 | | 0.27±0.14 | |